All members have the option of attending our various HTC-centric events which include:

Two in-person member meetings a year (in spring and fall)
Regular Webinars educating our members on HTC operations & organizational management, payer relations, regulations and legal updates, and advocacy

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Bayer – Clinical review of the Jivi® PROTECT VIII Trial and insights from HEM-POWR: A Real-World Evidence (RWE) Study of Jivi®

June 5, 2024 @ 1:00 pm - 2:00 pm

Date: Wednesday, June 5, 2024
Time: 1:00pm – 2:00pm ET

TOPIC:
Clinical review of the Jivi® PROTECT VIII Trial and insights from HEM-POWR: A Real-World Evidence (RWE) Study of Jivi®

WEBINAR OVERVIEW:

This session includes key information about Jivi including, safety and efficacy data from the clinical trials, step-wise dosing and Jivi RWE Data from the 4th interim analysis of HEM-POWR, a multinational, open-label, prospective, non-interventional, multicenter cohort study of Jivi.
There will also be a review of the Q2 2024 340B pricing for the Bayer Hemophilia A portfolio under the Hemophilia Alliance Contract.

SPEAKER:

Dr. Vanessa K. Salinas-Lunas
Pediatric Hematology
Center for Inherited Blood Disorders

SPEAKER’S BIO:
N/A